Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study. Gini G, Tani M, Tucci A, Marcheselli L, et al. Blood 2023;142:1438-1447.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gini G, Tani M, Tucci A, Marcheselli L, et al. Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study. Blood 2023;142:1438-1447.
PMID: 37418685